Exabis Library
Welcome to the e-CCO Library!
P144: Protozoa and bacterial infections are relevant for clinical outcomes in ulcerative colitis: a study from Latin American country
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P144: TNF-inhibitor use and efficacy in upper-GI Crohn’s disease: results from a multicentre retrospective study
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P145 Orofacial granulomatosis in Crohn’s disease: an ECCO CONFER multi-centre case series
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P145: Exploring mucosal function as a clinical endpoint in ulcerative colitis
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P145: Inflammatory Bowel Disease patients requiring surgery can be treated in referral centres regardless of the COVID-19 status of the hospital: results of a multicentric European study during the first COVID-19 outbreak (COVIBD-Surg)
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P145: Measuring access and quality of care indicators in inflammatory bowel disease in a tertiary referral center
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P145: Migraine is the most frequent extra-intestinal manifestation in patients with inflammatory bowel disease
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P145: Phenotypic progression of Crohn's disease : assessment of risk factors in a Tunisian population
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:48 AM
P145: Telephone straight-to-test (tSTT) improves early diagnosis of inflammatory bowel disease (IBD)
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P145: Ultrasonographic parameters associated with mucosal healing 1 year after infliximab therapy in Crohn’s Disease: a multicentric and prospective study
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P146 Comparison of three histologic indices in ulcerative colitis: Evaluation from the Phase 2 study of upadacitinib (U-ACHIEVE)
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P146: Dysplasia Surveillance in inflammatory bowel disease—a cohort study
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P146: Initial response to induction treatment more important than type of induction treatment for achieving sustained steroid free remission at 1 year in new-onset paediatric Crohn’s disease
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P146: Primary intestinal Epstein-Barr virus-associated NK/T-Cell lymphoproliferative disorder: a disease mimicking IBD
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P146: Risk factors of clinical relapse in patients with ulcerative colitis in clinical and endoscopic remission.
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P146: Stigmatization and resilience in inflammatory bowel disease patients at one-year follow-up
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:48 AM
P146: The Toronto IBD global endoscopic reporting (TIGER) score demonstrates significant correlation with fecal calprotectin, CRP and IBD Disk in Crohn's disease patients
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P146: Ultrasonography and perianal involvement in inflammatory bowel disease
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P147 Systematic review: diverting loop ileostomy as treatment option in severe inflammatory bowel disease
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P147: Do IBD Patient Treatment Outcomes Expectations Differ by Ethnicity and Gender?
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM